BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1334379)

  • 1. Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group.
    Ottesen GL; Graversen HP; Blichert-Toft M; Zedeler K; Andersen JA
    Am J Surg Pathol; 1992 Dec; 16(12):1183-96. PubMed ID: 1334379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
    Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA
    Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group.
    Ottesen GL; Graversen HP; Blichert-Toft M; Zedeler K; Andersen JA
    Am J Surg Pathol; 1993 Jan; 17(1):14-21. PubMed ID: 8383466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of screen detected ductal carcinoma in situ of the female breast.
    Carpenter R; Boulter PS; Cooke T; Gibbs NM
    Br J Surg; 1989 Jun; 76(6):564-7. PubMed ID: 2547496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal breast cancer: review of 183 consecutive cases.
    Cataliotti L; Distante V; Ciatto S; Bianchi S; Pacini P; Simoncini R; Rosselli Del Turco M; Cardona G; Falli F
    Eur J Cancer; 1992; 28A(4-5):917-20. PubMed ID: 1326310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone.
    Schwartz GF; Finkel GC; Garcia JC; Patchefsky AS
    Cancer; 1992 Nov; 70(10):2468-74. PubMed ID: 1330281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy.
    Rosner D; Lane WW; Penetrante R
    Cancer; 1991 Mar; 67(6):1498-503. PubMed ID: 1848153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
    Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
    Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.
    Hardman PD; Worth A; Lee U; Baird RM
    Can J Surg; 1989 Jan; 32(1):56-60. PubMed ID: 2535949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ carcinoma of the breast.
    Howard PW; Locker AP; Dowle CS; Ellis IO; Elston CW; Blamey RW
    Eur J Surg Oncol; 1989 Aug; 15(4):328-32. PubMed ID: 2547662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.
    Finkelstein SD; Sayegh R; Thompson WR
    Am Surg; 1993 Jul; 59(7):410-4. PubMed ID: 8391769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer survival among women under age 50: is mammography detrimental?
    Stacey-Clear A; McCarthy KA; Hall DA; Pile-Spellman E; White G; Hulka C; Whitman GJ; Mahoney E; Kopans DB
    Lancet; 1992 Oct; 340(8826):991-4. PubMed ID: 1357448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence.
    Lagios MD; Margolin FR; Westdahl PR; Rose MR
    Cancer; 1989 Feb; 63(4):618-24. PubMed ID: 2536582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The problem of ductal carcinoma in situ of the breast.
    Fentiman IS
    Ann Chir Gynaecol; 1992; 81(4):334-6. PubMed ID: 1336650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment.
    Andersen J; Blichert-Toft M; Dyreborg U
    Eur J Surg Oncol; 1987 Apr; 13(2):105-11. PubMed ID: 3030823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
    Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
    Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
    Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
    Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.